Tralokinumab Safe, Effective in Phase 3 Atopic Dermatitis Trials
LEO Pharma announced positive topline results from three pivotal phase 3 studies of tralokinumab for the treatment of adults with moderate-to-severe atopic dermatitis.
Atopic Dermatitis
FDA Grants Fast Track Status to Lebrikizumab for Atopic Dermatitis
The FDA has granted Fast Track designation to lebrikizumab for the treatment of moderate-to-severe atopic dermatitis.
Family Constellation Seminars Reduce Itch Associated With Atopic Dermatitis, Psoriasis
Participation in 4 therapy seminars resulted in appreciable improvement in pruritus in patients with atopic dermatitis or psoriasis and may be an efficient supplementary method for managing chronic itch in these populations.
Depression Screening Rates Low in Patients With Psoriasis, Atopic Dermatitis
Despite well-established associations of psoriasis and atopic dermatitis with depression and suicidality, and recommendations for increased screening in these higher-risk patients, clinical practice gaps remain, with low rates of depression screening.
Inflammatory, Atherosclerosis/Cardiovascular Signature in Atopic Dermatitis
Skin rather than blood is the primary source for the inflammatory and atherosclerosis/cardiovascular signature, data from this novel study suggests.
Pediatric Atopic Dermatitis Linked to Clinically Significant Mental Health Symptoms
Atopic dermatitis is associated with clinically significant mental health symptoms, but nearly half of children with atopic dermatitis and severe mental health impairments may not receive mental healthcare, suggesting a critical practice gap.
PO SCORAD for Black Skin a Valuable Tool for Evaluating AD
PO-SCORAD for black skin is a simple tool that allows patients to easily self-assess atopic dermatitis severity. It may prove a valuable tool for monitoring disease severity between physician visits and involving patients in the management of their disease.
The Role of Gut Microbiome in Inflammatory and Allergic Skin Diseases
This review gives insight into the role of gut microbiome alterations in the pathogenesis of psoriasis, acne, rosacea, hidradenitis suppurativa, and atopic dermatitis.
Pharmacotherapy Trends for Atopic Dermatitis in the US
Although the atopic dermatitis treatment patterns found reflect existing clinical guidelines, second-generation antihistamines are not recommended in the management of atopic dermatitis, despite being the third most prescribed medication class.
Expert Roundtable: Comorbidities in Atopic Dermatitis
Atopic dermatitis, especially severe atopic dermatitis, is associated with allergic, autoimmune, and cardiovascular comorbidities.
Next post in Dermatitis
